Compound B35（Shenyang Pharmaceutical University）

化合物B35（沈阳药科大学）

Report date: 2022/06/27 16:49:25
NME

Base Information

Drug NameCompound B35（Shenyang Pharmaceutical University）
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysine-specific histone demethylase 1 inhibitors
TargetsLysine-specific histone demethylase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenyang Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesShenyang Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A